Other studies have suggested that this pathophysiology may be relevant to different MPS types [6,7,8,9], with clinical studies implicating TNF-α as a prognostic value in MPS [10] and perhaps even a therapeutic target [24,25]. The gene discussed is TNF; the disease is mucopolysaccharidosis.